The Training Program in Molecular and Translational Hematology is designed to prepare physicians and postdoctoral scientists for independent, research-oriented careers in hematology. The program draws on the research interests and expertise of 18 funded faculty members in the Divisions of Pediatric and Adult Hematology/Oncology, Departments of Pathology, Biological Chemistry, Molecular Medicine and Genetics, Cellular and Developmental Biology, Cellular and Molecular Biology, the Life Sciences Institute and the Howard Hughes Institute at the University of Michigan. Active areas of research include 1) molecular and cell biology of the immune system;2) molecular basis of neoplastic cell growth;3) molecular biology of hemostasis and thrombosis;and 4) translational research in blood and marrow transplantation. A Selection/Monitoring Committee recruits MD or PhD trainees with strong academic credentials who desire a scholarly career encompassing hematology teaching and research. MD trainees will have had 3 years of house officer training in Pediatrics or Internal Medicine and a year of clinical training in Pediatric or Adult Hematology/Oncology. PhD trainees will have a major interest in hematology-related research. Prior to starting in the laboratory, MD trainees are strongly encouraged to participate in a two-month Postgraduate Research Training Program in Cell and Molecular Biology. Trainees then spend 2-3 years in the lab under supervision of a faculty Lab Mentor, developing expertise in posing feasible scientific questions, acquiring skills to answer these questions, and critically evaluating data obtained. During their laboratory training, trainees are continuously mentored and evaluated semi-annually by a Mentoring Committee. Trainees present the results of their investigations, participate in discussions of data obtained by their colleagues, attend relevant research seminars and interact with faculty members in basic and translational sciences. During the course of training, each trainee is expected to author at least one research manuscript.
The goal of this Program is to produce trainees successful in pursuing careers in academic hematology. Improved understanding of the mechanisms of hematologic diseases (including cancers such as leukemia and lymphoma) and of translational approaches of this improved understanding will lead to more effective and less toxic treatments for these conditions.
|Bailey, Kelly M; Airik, Merlin; Krook, Melanie A et al. (2016) Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma. Neoplasia 18:480-8|
|Weyand, Angela C; Lombel, Rebecca M; Pipe, Steven W et al. (2016) The Role of Platelets and Îµ-Aminocaproic Acid in Arthrogryposis, Renal Dysfunction, and Cholestasis (ARC) Syndrome Associated Hemorrhage. Pediatr Blood Cancer 63:561-3|
|Pedersen, Elisabeth A; Menon, Rajasree; Bailey, Kelly M et al. (2016) Activation of Wnt/Î²-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States. Cancer Res 76:5040-53|
|Rost, M S; Grzegorski, S J; Shavit, J A (2016) Quantitative methods for studying hemostasis in zebrafish larvae. Methods Cell Biol 134:377-89|
|Kretz, Colin A; Weyand, Angela C; Shavit, Jordan A (2015) Modeling Disorders of Blood Coagulation in the Zebrafish. Curr Pathobiol Rep 3:155-161|
|Krook, Melanie A; Nicholls, Lauren A; Scannell, Christopher A et al. (2014) Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma. Mol Cancer Res 12:953-64|
|Castro, Maria G; Candolfi, Marianela; Wilson, Thomas J et al. (2014) Adenoviral vector-mediated gene therapy for gliomas: coming of age. Expert Opin Biol Ther 14:1241-57|
|Kim, Edward; Wang, Yuan; Kim, Sun-Jung et al. (2014) Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. Elife 3:|
|Kenneth, Niall S; Hucks Jr, George E; Kocab, Andrew J et al. (2014) Copper is a potent inhibitor of both the canonical and non-canonical NFÎºB pathways. Cell Cycle 13:1006-14|
|Baker, Gregory J; Yadav, Viveka Nand; Motsch, Sebastien et al. (2014) Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia 16:543-61|
Showing the most recent 10 out of 46 publications